Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · IEX Real-Time Price · USD
0.157
-0.012 (-6.84%)
At close: Apr 18, 2024, 4:00 PM
0.159
+0.002 (1.21%)
After-hours: Apr 18, 2024, 6:35 PM EDT
Sonoma Pharmaceuticals Market Cap
Sonoma Pharmaceuticals has a market cap or net worth of $2.44 million as of April 18, 2024. Its market cap has decreased by -44.45% in one year.
Market Cap
2.44M
Enterprise Value
423.12K
1-Year Change
-44.45%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since January 25, 2007, Sonoma Pharmaceuticals's market cap has decreased from $92.80M to $2.44M, a decrease of -97.37%. That is a compound annual growth rate of -19.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 2.50M | -3.85% |
Apr 17, 2024 | 2.60M | - |
Apr 16, 2024 | 2.60M | 4.00% |
Apr 15, 2024 | 2.50M | -7.41% |
Apr 12, 2024 | 2.70M | 3.85% |
Apr 11, 2024 | 2.60M | -3.70% |
Apr 10, 2024 | 2.70M | 12.50% |
Apr 9, 2024 | 2.40M | 4.35% |
Apr 8, 2024 | 2.30M | -4.17% |
Apr 5, 2024 | 2.40M | -4.00% |
Apr 4, 2024 | 2.50M | - |
Apr 3, 2024 | 2.50M | 8.70% |
Apr 2, 2024 | 2.30M | -4.17% |
Apr 1, 2024 | 2.40M | -7.69% |
Mar 28, 2024 | 2.60M | - |
Mar 27, 2024 | 2.60M | 4.00% |
Mar 26, 2024 | 2.50M | 13.64% |
Mar 25, 2024 | 2.20M | - |
Mar 22, 2024 | 2.20M | 4.76% |
Mar 21, 2024 | 2.10M | - |
Mar 20, 2024 | 2.10M | -8.70% |
Mar 19, 2024 | 2.30M | 4.55% |
Mar 18, 2024 | 2.20M | 4.76% |
Mar 15, 2024 | 2.10M | - |
Mar 14, 2024 | 2.10M | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Onconetix | 2.86M |
cbdMD | 2.80M |
Dynatronics | 2.78M |
60 Degrees Pharmaceuticals | 2.75M |
ENDRA Life Sciences | 2.70M |
SCWorx | 2.60M |
NovaBay Pharmaceuticals | 2.60M |
Cyclacel Pharmaceuticals | 2.58M |